Carotid endarterectomy

Stephen E. Nadeau, John R. Crouse, Amy P. Hagaman, M. K. Floeter, Neil A. Solomon, Alan Yudell, D. W. Taylor, R. B. Haynes, D. L. Sackett, H. J.M. Barnett, G. G. Ferguson, M. Eliasziw, V. C. Hachinski, J. Philip Kistler, Ferdinando S. Buonanno, Daryl R. Gress

Research output: Contribution to journalLetterpeer-review


To the Editor: The study population of the North American Symptomatic Carotid Endarterectomy Trial (NASCET) consisted of three groups: patients with retinal transient ischemic attack or stroke (28 percent), hemispheric transient ischemic attack (38 percent), and hemispheric stroke (34 percent) (Aug. 15 issue).1 , 2 There is evidence that the natural history of these three types of patients may be quite different. Three studies of the natural history of amaurosis fugax or retinal infarction have demonstrated five-year rates of stroke or permanent visual loss of 13.1 percent,3 20.3 percent,4 and 24.2 percent.5 By contrast, an important study of the natural history of.

Original languageEnglish (US)
Pages (from-to)762-765
Number of pages4
JournalNew England Journal of Medicine
Issue number11
StatePublished - Mar 12 1992
Externally publishedYes

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Carotid endarterectomy'. Together they form a unique fingerprint.

Cite this